a.Time taken for clinical recovery; which is defined as; <br/ >1. Normalization of pyrexia and body pain <br/ >2. Respiratory rate less than 24/minute <br/ >3.Spo2 rate greater than 94% <br/ >4. Relief from cough and maintenance of above for more than 72 hours. <br/ >b.Proportion of patients with swabs negative for COVID19 in RT PCR at day 5; 10 and 15 <br/ >c.Reduction of Viral Load. <br/ >Timepoint: At day 5; day 10 and day 15

a.Time taken for clinical recovery; which is defined as; <br/ >1. Normalization of pyrexia and body pain <br/ >2. Respiratory rate less than 24/minute <br/ >3.Spo2 rate greater than 94% <br/ >4. Relief from cough and maintenance of above for more than 72 hours. <br/ >b.Proportion of patients with swabs negative for COVID19 in RT PCR at day 5; 10 and 15 <br/ >c.Reduction of Viral Load. <br/ >Timepoint: At day 5; day 10 and day 15

N/A

N/A

a.Time taken for clinical recovery; which is defined as; <br/ >1. Normalization of pyrexia and body pain <br/ >2. Respiratory rate less than 24/minute <br/ >3.Spo2 rate greater than 94% <br/ >4. Relief from cough and maintenance of above for more than 72 hours. <br/ >b.Proportion of patients with swabs negative for COVID19 in RT PCR at day 5; 10 and 15 <br/ >c.Reduction of Viral Load. <br/ >Timepoint: At day 5; day 10 and day 15

a.Time taken for clinical recovery; which is defined as; <br/ >1. Normalization of pyrexia and body pain <br/ >2. Respiratory rate less than 24/minute <br/ >3.Spo2 rate greater than 94% <br/ >4. Relief from cough and maintenance of above for more than 72 hours. <br/ >b.Proportion of patients with swabs negative for COVID19 in RT PCR at day 5; 10 and 15 <br/ >c.Reduction of Viral Load. <br/ >Timepoint: At day 5; day 10 and day 15